Atlas Trials

A Safety And Immunogenicity Study Of A 13-valent Pneumococcal Conjugate Vaccine In Japanese Subjects Aged 6 To 64 Years.

Clinical trial NCT03571607 · COMPLETED

Trial details

NCT number
NCT03571607
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Pneumococcal Infections
Start date
2018-07-12
Primary completion
2018-11-16
Enrollment
206

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.